| Literature DB >> 35778678 |
Yuan Zhang1, Yuzhong Zhuang1, Yaqiong Ge2, Pu-Yeh Wu3, Jing Zhao4, Hao Wang5, Bin Song6.
Abstract
BACKGROUND: This study aims is to explore whether it is feasible to use magnetic resonance texture analysis (MRTA) in order to distinguish favorable from unfavorable function outcomes and determine the prognostic factors associated with favorable outcomes of stroke.Entities:
Keywords: Apparent diffusion coefficient; Function outcomes; Magnetic resonance imaging; Texture analysis
Mesh:
Year: 2022 PMID: 35778678 PMCID: PMC9250246 DOI: 10.1186/s12880-022-00845-y
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 2.795
Fig. 1Flow chart of the patient enrollment and the modeling process. IC infarcted core, TA texture analysis, MRI magnetic resonance imaging
Fig. 2The patient was a 61-year-old male with subacute cerebral infarction in the left basal ganglia and the frontal lobe; the favorable outcome for day 90 mRS score is 2 (a–c). a Axial DWI (b = 1000) shows an obvious uniform hyperintense area (red), the infarct volume was 58.81 ml. b The ADC map shows an hypointense area within the diffusion-restricted region (red). c ADC histogram, the abscissa is the ADC value, and the ordinate is the pixel value. The patient was a 61-year-old male with a subacute cerebral infarction in the left basal ganglia and the frontal lobe; the unfavorable outcome for the 90-day mRS score is 3 (d–f). d Axial DWI (b = 1000) shows an obvious uniform hyperintense area (red), the infarct volume was 110.71 ml. e ADC map shows an hypointense area in the diffusion-restricted region (red). f. ADC histogram, the abscissa is the ADC value, and the ordinate is the pixel value
Clinical characteristics of patients in the favorable and unfavorable groups
| Variable | Favorable Outcome (N = 46) | Unfavorable Outcome (N = 57) | |
|---|---|---|---|
| Age, years | 65.22 ± 12.22 | 65.60 ± 13.44 | 0.883 |
| Sex male, n (%) | 32 (69.57) | 34 (59.65) | 0.297 |
| Hypertension, n (%) | 28 (60.87) | 41 (71.93) | 0.235 |
| Diabetes mellitus, n (%) | 13 (28.26) | 22 (38.60) | 0.271 |
| Smoking, n (%) | 8 (17.39) | 15 (26.32) | 0.280 |
| Atrial fibrillation, n (%) | 3 (6.52) | 14 (24.56) | 0.014* |
| History of stroke, n (%) | 6 (13.04) | 15 (26.32) | 0.096 |
| Homocysteine, mL | 16.67 ± 17.03 | 15.63 ± 13.49 | 0.503 |
| Hemorrhage, n (%) | 3 (6.52) | 13 (22.81) | 0.023* |
| IC volume, mL | 15.90 ± 16.10 | 57.05 ± 63.17 | 0.000* |
| Mean ADC value (10−3 mm2/s) | 0.40 ± 0.12 | 0.36 ± 0.08 | 0.041* |
| NIHSSbaseline, median (P25, P75) | 5 (3, 7) | 7 (4, 10) | 0.000* |
| NIHSSdischarge, median (P25, P75) | 4 (1, 7) | 7 (5, 10) | 0.000* |
| mRSbaseline, median (range) | 3 (0–4) | 4 (1–5) | 0.000* |
| mRSdischarge, median (range) | 2 (0–4) | 4 (2–5) | 0.000* |
| Scanner, n (%) | 0.306 | ||
| 3.0 T MRI | 36 (78.26) | 49 (85.96) | |
| 1.5 T MRI | 10 (21.74) | 8 (14.04) | |
| Time from onset to MR, hours | 57.7 ± 22.0 | 60.5 ± 18.8 | 0.485 |
IC infarcted core, ADC apparent diffusion coefficient, NIHSS National Institutes of Health Stroke Scale, NIHSS baseline NIHSS score on admission, NIHSS NIHSS score on discharge, mRS modified rankin scale, mRS baseline mRS score on admission, mRS mRS score on discharge, MRI magnetic resonance imaging
*P < 0.05
Multivariate regression of texture features in the tADC and tADC combined model
| Model/Texture features | OR | 95% CI | Reg coefficient | ||
|---|---|---|---|---|---|
| Wavelet_LLL_firstorder_Energy | 16.63 | 2.22 | 124.58 | 2.811 | 0.006* |
| Wavelet_LLL_firstorder_Minimum | 0.54 | 0.27 | 1.08 | − 0.617 | 0.081 |
| Wavelet_LLH_firstorder_Maximum | 2.08 | 0.89 | 4.86 | 0.733 | 0.090 |
| Log_sigma_5_mm_3D_firstorder_Kurtosis | 1.76 | 1.04 | 3.00 | 0.568 | 0.036* |
| Log_sigma_4_mm_3D_firstorder_Skewness | 2.91 | 1.45 | 5.84 | 1.069 | 0.003* |
| Log_sigma_2_mm_3D_firstorder_Median | 1.66 | 0.83 | 3.32 | 0.509 | 0.149 |
| Log_sigma_4_mm_3D_firstorder_Maximum | 0.49 | 0.22 | 1.11 | − 0.711 | 0.088 |
| Atrial_fibrillation | 1.83 | 0.99 | 3.38 | 0.604 | 0.054 |
| Wavelet_LLL_firstorder_Energy | 8.17 | 1.53 | 43.65 | 2.101 | 0.014* |
| Wavelet_LLL_firstorder_Minimum | 0.56 | 0.29 | 1.10 | − 0.572 | 0.094 |
| Wavelet_LLL_firstorder_Range | 2.33 | 0.87 | 6.23 | 0.846 | 0.092 |
| Wavelet_LLH_firstorder_Maximum | 3.16 | 1.15 | 8.69 | 1.150 | 0.026* |
| Log_sigma_5_mm_3D_firstorder_Kurtosis | 1.47 | 0.88 | 2.48 | 0.388 | 0.144 |
| Log_sigma_4_mm_3D_firstorder_Skewness | 5.01 | 1.97 | 12.76 | 1.611 | 0.001* |
| Log_sigma_2_mm_3D_firstorder_Median | 2.11 | 0.96 | 4.63 | 0.746 | 0.063 |
| Log_sigma_4_mm_3D_firstorder_Maximum | 0.26 | 0.09 | 0.77 | − 1.347 | 0.016* |
tADC texture features on ADC map, tADC Combined, tADC + clinical characteristics, OR odds ratio, CI confidence interval, Reg regression
*P < 0.05
Fig. 3The ROC curve of the models used to assess stroke outcome. ROC receiver operating characteristic, ADC apparent diffusion coefficient, tADC texture features on ADC map
Fig. 4Boxplot of the 100 results of a 10 times tenfold cross-validation